Meeting abstract
https://doi.org/10.33004/reumatizam-supp-73-1-29
Changing the management of systemic vasculitis: the era of targeted therapies
Roberto Padoan
*
* Corresponding author.
Full text: english pdf 1.030 Kb
page 34-34
downloads: 0
cite
APA 6th Edition
Padoan, R. (2026). Changing the management of systemic vasculitis: the era of targeted therapies. Reumatizam, 73 (Supp 1), 34-34. https://doi.org/10.33004/reumatizam-supp-73-1-29
MLA 8th Edition
Padoan, Roberto. "Changing the management of systemic vasculitis: the era of targeted therapies." Reumatizam, vol. 73, no. Supp 1, 2026, pp. 34-34. https://doi.org/10.33004/reumatizam-supp-73-1-29. Accessed 4 Nov. 2026.
Chicago 17th Edition
Padoan, Roberto. "Changing the management of systemic vasculitis: the era of targeted therapies." Reumatizam 73, no. Supp 1 (2026): 34-34. https://doi.org/10.33004/reumatizam-supp-73-1-29
Harvard
Padoan, R. (2026). 'Changing the management of systemic vasculitis: the era of targeted therapies', Reumatizam, 73(Supp 1), pp. 34-34. https://doi.org/10.33004/reumatizam-supp-73-1-29
Vancouver
Padoan R. Changing the management of systemic vasculitis: the era of targeted therapies. Reumatizam [Internet]. 2026 [cited 2026 November 04];73(Supp 1):34-34. https://doi.org/10.33004/reumatizam-supp-73-1-29
IEEE
R. Padoan, "Changing the management of systemic vasculitis: the era of targeted therapies", Reumatizam, vol.73, no. Supp 1, pp. 34-34, 2026. [Online]. https://doi.org/10.33004/reumatizam-supp-73-1-29
Abstract
Keywords
systemic vasculitis, targeted therapies, biologic therapy, ANCA-associated vasculitis, giant cell arteritis
Hrčak ID:
352812
URI
https://hrcak.srce.hr/352812
Publication date:
21.10.2026.
Article data in other languages:
croatian
Visits: 0
*